Insider · CIK 0001497166

Arrow Alexander K.

Reports to the SEC for 4 companies · IRVINE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001497166

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-03-25	PTIXProtagenic Therapeutics, Inc.\new · PTIX Common stock OptionsA Award	Chief Financial Officer	AAward	+100K sh	$1.74	+$174K	100,000
2023-10-12	PTIXProtagenic Therapeutics, Inc.\newP Purchase	Chief Financial Officer	PPurchase	+8,000 sh	$0.81	+$6,480	45,815
2022-05-18	PTIXProtagenic Therapeutics, Inc.\newP Purchase	Chief Financial Officer	PPurchase	+8,000 sh	$0.72	+$5,760	151,260
2022-05-17	PTIXProtagenic Therapeutics, Inc.\newP Purchase	Chief Financial Officer	PPurchase	+23K sh	$0.71	+$16.3K	143,260
2021-06-03	PTIXProtagenic Therapeutics, Inc.\new · PTIXW Common Stock 5-year warrants strike price $4.98P Purchase	Chief Financial Officer	PPurchase	+16.9K sh	$0.38	+$6,422	50,000
2021-06-02	PTIXProtagenic Therapeutics, Inc.\new · PTIXW Common Stock 5-year warrants strike price $4.98P Purchase	Chief Financial Officer	PPurchase	+100 sh	$0.38	+$38	33,100
2021-05-27	PTIXProtagenic Therapeutics, Inc.\new · PTIXW Common Stock 5-year warrants strike price $4.98P Purchase	Chief Financial Officer	PPurchase	+3,000 sh	$0.38	+$1,140	33,000
2021-05-18	PTIXProtagenic Therapeutics, Inc.\new · PTIXW Common Stock 5-year warrants strike price $4.98P Purchase	Chief Financial Officer	PPurchase	+12K sh	$0.32	+$3,840	12,000
2021-05-18	PTIXProtagenic Therapeutics, Inc.\new · PTIXW Common Stock 5-year warrants strike price $4.98P Purchase	Chief Financial Officer	PPurchase	+18K sh	$0.31	+$5,580	30,000
2021-04-30	PTIXProtagenic Therapeutics, Inc.\newP Purchase	Chief Financial Officer	PPurchase	+1,000 sh	$2.29	+$2,290	120,260
2021-04-29	PTIXProtagenic Therapeutics, Inc.\newP Purchase	Chief Financial Officer	PPurchase	+1,000 sh	$2.29	+$2,290	119,260
2020-07-18	PTIXProtagenic Therapeutics, Inc.\new · PTIX Common stock OptionsA Award	Chief Financial Officer	AAward	+125K sh	$1.75	+$219K	124,998
2020-02-21	PTIXProtagenic Therapeutics, Inc.\new · PTIX Common stock OptionsA Award	Chief Financial Officer	AAward	+307K sh	—	—	307,497
2019-03-20	PTIXProtagenic Therapeutics, Inc.\new · PTIX Common stock OptionsA Award	Chief Financial Officer	AAward	+41.7K sh	—	—	41,667
2017-10-16	PTIXProtagenic Therapeutics, Inc.\new · Non-Qualified Stock Options (Right to Buy)A Award	Chief Financial Officer	AAward	+75K sh	—	—	75,000
2016-06-17	PTIXProtagenic Therapeutics, Inc.\newA Award	Chief Financial Officer	AAward	+140K sh	$1.25	+$175K	358,260
2016-04-15	PTIXProtagenic Therapeutics, Inc.\new · Series B Preferred StockP Purchase	Chief Financial Officer	PPurchase	+40K sh	$1.25	+$50K	100,000
2016-04-15	PTIXProtagenic Therapeutics, Inc.\new · Series B Preferred StockP Purchase	Chief Financial Officer	PPurchase	+18.3K sh	$1.25	+$22.8K	118,260
2014-07-22	BIOLASE, INCP Purchase	President and COO	PPurchase	+7,812 sh	$1.92	+$15K	110,387
2013-06-06	BIOLASE, INCStock Option (right to buy)A Award	President and COO	AAward	+350K sh	—	—	474,500
2012-08-14	BIOLASE, INCP Purchase	President and COO	PPurchase	+4,800 sh	$1.67	+$8,016	101,452
2012-08-14	BIOLASE, INCP Purchase	President and COO	PPurchase	+377 sh	$1.70	+$640.9	96,652
2012-08-14	BIOLASE, INCP Purchase	President and COO	PPurchase	+1,237 sh	$1.73	+$2,140.01	96,275
2012-08-14	BIOLASE, INCP Purchase	President and COO	PPurchase	+400 sh	$1.69	+$676	102,575
2012-08-14	BIOLASE, INCP Purchase	President and COO	PPurchase	+1,100 sh	$1.72	+$1,892	95,038
2012-08-14	BIOLASE, INCP Purchase	President and COO	PPurchase	+1,363 sh	$1.71	+$2,330.73	93,998
2012-08-14	BIOLASE, INCP Purchase	President and COO	PPurchase	+723 sh	$1.68	+$1,214.64	102,175
2012-08-13	BIOLASE, INCP Purchase	President and COO	PPurchase	+300 sh	$1.74	+$522	63,475
2012-08-13	BIOLASE, INCP Purchase	President and COO	PPurchase	+1,300 sh	$1.71	+$2,223	56,875
2012-08-13	BIOLASE, INCP Purchase	President and COO	PPurchase	+1,900 sh	$1.72	+$3,268	58,775
2012-08-13	BIOLASE, INCP Purchase	President and COO	PPurchase	+4,400 sh	$1.73	+$7,612	63,175
2012-08-13	BIOLASE, INCP Purchase	President and COO	PPurchase	+1,600 sh	$1.75	+$2,800	65,075
2012-08-13	BIOLASE, INCP Purchase	President and COO	PPurchase	+3,200 sh	$1.76	+$5,632	68,275
2012-08-13	BIOLASE, INCP Purchase	President and COO	PPurchase	+7,500 sh	$1.77	+$13.3K	75,775
2012-08-13	BIOLASE, INCP Purchase	President and COO	PPurchase	+300 sh	$1.78	+$534	76,075
2012-08-13	BIOLASE, INCP Purchase	President and COO	PPurchase	+9,000 sh	$1.80	+$16.2K	85,075
2012-08-13	BIOLASE, INCP Purchase	President and COO	PPurchase	+7,500 sh	$1.83	+$13.7K	92,575
2012-06-01	BIOLASE, INCP Purchase	President and COO	PPurchase	+3,000 sh	$2.36	+$7,080	55,575
2012-06-01	BIOLASE, INCP Purchase	President and COO	PPurchase	+200 sh	$2.39	+$478	52,575
2012-06-01	BIOLASE, INCP Purchase	President and COO	PPurchase	+1,600 sh	$2.33	+$3,728	52,375
2012-05-15	BIOLASE, INCA Award	President and COO	AAward	+2,000 sh	$2.41	+$4,820	50,775
2012-05-15	BIOLASE, INCP Purchase	President and COO	PPurchase	+2,000 sh	$2.41	+$4,820	50,775
2012-05-10	BIOLASE, INCStock Option (right to buy)A Award	President and COO	AAward	+20K sh	—	—	124,500
2011-08-18	BIOLASE, INCP Purchase	President and COO	PPurchase	+5,000 sh	$2.84	+$14.2K	48,775
2011-08-17	BIOLASE, INCP Purchase	President and COO	PPurchase	+2,800 sh	$2.85	+$7,980	43,500
2011-08-16	BIOLASE, INCP Purchase	President and COO	PPurchase	+5,000 sh	$2.97	+$14.9K	40,700
2011-08-15	BIOLASE, INCP Purchase	President and COO	PPurchase	+5,000 sh	$3.13	+$15.7K	35,700
2011-08-15	BIOLASE, INCP Purchase	President and COO	PPurchase	+6,200 sh	$3.05	+$18.9K	30,700
2011-05-31	BIOLASE, INCStock Option (right to buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−10K sh	$1.15	−$11.5K	94,500
2011-05-31	BIOLASE, INCM Exercise/Conversion	President and COO	MExercise/Conversion	+10K sh	$1.15	+$11.5K	24,500

Recent filings

Accepted (ET)
Mar 294
Arrow Alexander K.0001493152-24-012069
SEC(opens sec.gov)
Oct 134
Arrow Alexander K.0001493152-23-037136
SEC(opens sec.gov)
May 184
Arrow Alexander K.0001493152-22-014338
SEC(opens sec.gov)
Jun 34
Arrow Alexander K.0001493152-21-013554
SEC(opens sec.gov)
Jun 14
Arrow Alexander K.0001493152-21-013279
SEC(opens sec.gov)
May 204
Arrow Alexander K.0001493152-21-012357
SEC(opens sec.gov)
May 34
Arrow Alexander K.0001493152-21-010335
SEC(opens sec.gov)
Jul 214
Arrow Alexander K.0001493152-20-013712
SEC(opens sec.gov)
Feb 264
Arrow Alexander K.0001493152-20-003033
SEC(opens sec.gov)
Mar 254
Arrow Alexander K.0001493152-19-003805
SEC(opens sec.gov)
Oct 184
Arrow Alexander K.0001437749-17-017238
SEC(opens sec.gov)
Jun 214
Protagenic Therapeutics, Inc.\new0001437749-16-034203
SEC(opens sec.gov)
May 104
Atrinsic, Inc.0001437749-16-031405
SEC(opens sec.gov)
Jul 234
BIOLASE, INC0001209191-14-048749
SEC(opens sec.gov)
Jun 114
BIOLASE, INC0001209191-13-031630
SEC(opens sec.gov)

Companies

Address

C/O 4 CROMWELL

IRVINE, CA, 92618